Well ... I guess it does look like I am playing devil's advocate. I think I am raising or asking valid points on this board. I see risks and either try to eliminate them or measure them.
When a sure thing fails its usually poor management that's the cause. That is something I like about Arth... management seems so careful and purposeful in their approach to each step. Of course I can't be positive, but it is the feeling get watching from the outside.
I will go further to say that I believe management will look to partner, rather than dilute our shares at such low prices, in order to fund further trials. Again I am speculating that if there is more dilution it will not be much if at all.
News 
Market Data 
Discover 
